Complementary adenoviral systems and cell lines

Details Complementary adenoviral systems and cell lines Complementary adenoviral systems and cell lines

1995-12-14

1998-12-22

Guzo, David

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

4353201, 435325, 435366, 536 242, C12P 1934, C12N 1511, C12N 516, C12N 522

Patent

active

058518061

ABSTRACT:
The present invention provides multiply replication deficient adenoviral vectors having a spacer in at least one replication deficient adenoviral region, as well as complementing cell lines therefor. Also provided are means of constructing the multiply replication deficient adenoviral vectors and methods of use thereof, e.g., in gene therapy.

REFERENCES:
patent: 4405712 (1983-09-01), Vande Woude
Brough et al., Virology, 190, 624-634 (1992).
Fallaux et al., Human Gene Therapy, 7, 215-222 (1996).
Graham et al., J. Gen. Virol., 36, 59-72 (1977).
Imler et al., Gene Therapy, 3, 75-84 (1996).
Klessig et al., Molecular and Cellular Biology, 4(7), 1354-1362 (1984).
Kreeger, The Scientist, 13, (Feb. 19, 1996).
Krougliak et al., Human Gene Therapy, 6, 1575-1586 (1995).
Schaack et al., J. Virol., 4079-4085 (1995).
Wang et al., Gene Therapy, 2, 775-783 (1995).
Weinberg et al., Proc. Natl. Acad. Sci., 80, 5383-86 (1983).
Yeh et al., J. Virol., 70(1), 559-565 (1996).
Barr et al., "Efficient Catheter-Mediated Gene Transfer Into The Heart Using Replication-Defective Adenovirus," Gene Therapy, 1:51-58 (1994).
Berkner et al., "Generation of Adenovirus By Transfection of Plasmids," Nucleic Acids Research, 1117:6003-6020 (1983).
Boucher et al., "Gene Therapy For Cystic Fibrosis Using El-Deleted Adenovirus: A Phase I Trial In The Nasal Cavity," Human Gene Therapy, 5:615-639 (1994).
Brough et al., "Construction, Characterization, and Utilization of Cell Lines Which Inducibly Express the Adenovirus DNA-Binding Protein," Virology, 190:624-634 (1992).
Davidson et al., "Overproduction of Polyomavirus Middle T Antigen in Mammalian Cells Through the Use of an Adenovirus Vector," Journal of Virology, 61(4):1226-1239 (1987).
Engelhardt et al., "Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Biological Efficacy Study," Humna Gene Therapy, 4:759-769 (1993).
Klessing et al., "Introduction, Stable Intergration, and Controlled Expression of a Chimeric Adenovirus Gene Whose Product Is Toxic to the Recipient Human Cell," Molecular and Cellular Biology, 4(7):1354-1362.
Weinberg et al., "A Cell Line that Supports the Growth of a Defective Early Region 4 Deletion Mutant of Human Adenovirus Type 2," Proc. Natl. Acad. Sci. USA, 80:5383-5386 (1983).
Yang et al., "Cellular Immunity to Viral Antigens Limits El-Deleted Adenoviruses for Gene Therapy," Proc. Natl. Acad. Sci. USA, 91:4407-4411 (1994).
Armentano et al., "Characterization of an Adenovirus Gene Transfer Vector Containing an E4 Deletion," Human Gene Therapy 6:1343-1353 (1995).
Berkner, "Development of Adenovirus Vectors for the Expression of Heterologous Genes," BioTechniques, vol. 6, No. 7, 616-629 (1988).
Bout et al., "Lung Gene Therapy: In Vivo Adenvirus-Mediated Gene Transfer to Rhesus Monkey Airway Epithelium," Human Gene Therapy 5:3-10 (1994).
Brough et al., "Multiple Functions of the Adenovirus DNA-Binding Protein Are Required for Efficient Viral DNA Synthesis," Virology, 196:269-281 (1993).
Crystal et al., "Administration of an adenovirus containing the human cFTR cDNA to the respiratory tract of individuals with cystic fibrosis," Nature Genetics, vol. 8, (Sep. 1994).
Gilardi et al., "Expression of human .alpha..sub.1 -antitrypsin using a recombinant adenvirus vector," FEBS, vol. 267, No. 1, 60-62 (Jul. 1990).
Lemarchand et al., "Adenovirus-mediated transfer of a recombinant human .alpha..sub.1 -antitrypsin cDNA to human endothelial cells," Proc. Natl. Acad. Sci. USA, vol. 89, pp. 6482-6486, (Jul. 1992).
Mastrangeli et al., "Diversity of Airway Epithelial Cell Targets for In Vivo Recombinant Adenovirus-mediated Gene Transfer," The Journal of Clinical Investigation, Inc., vol. 91, 225-234 (Jan. 1993).
Mittereder et al., "In Vivo Evaluation of the Safety if Adenovirus-Medicated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lung," Human Gene Therapy 5:731-744 (1994).
Mittereder et al., "Evaluation of the Efficacy and Safety of In Vitro, Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA," Human Gene Therapy 5:717-729 (1994).
Morin et al., "Nuclear Localization of the Adenovirus DNA-Binding Protein: Requirement for TWo Signals and Complementation during Viral Infection," Molecular and Cellular Biology, pp. 4372-4380 (Oct. 1989).
Rosenfeld et al., "In Vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to the Airway Epithelium," Cell, vol. 68, 143-155 (Jan. 10, 1992).
Simon et al., "Adenovirus-Mediated Transfer of the CFTR Gene To Lung of Nonhuman Primates: Toxicity Study," Human Gene Therapy 4:771-780 (1993).
Simon et al., "Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Toxicity Study," Human Gene Therapy 4:771-780 (1993).
Trapnell et al., "Gene therapy using adenoviral vectors," Current Opinion in Biotechnology, 5:617-625 (1994).
Vos et al., "Charaterization of Adenovirus Type 5 Insertion and Deletion Mutants Encoding Altered DNA Binding Proteins," Virology 172:634-642 (1989).
Yang et al., "Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis," Nature Genetics, vol. 7 pp. 362-369, (Jul. 1994).
Cleghon et al., J. Virology, 63, 2289-2299 (1989).
Rice et al., Virology, 156 (2), 366-376 (1987).
Stuiver et al., J. Virology, 65:379-386 (1990).

Affiliated with

Also associated with

Rating

Complementary adenoviral systems and cell lines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Complementary adenoviral systems and cell lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complementary adenoviral systems and cell lines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2046084